Join us virtually at World Vaccine Congress (WVC)

from September 28 - October 1, 2020 for insights on how we can help your vaccine trials.

FHI Clinical is providing clinical operations services and expertise for the

Global ACTT study of potential COVID-19 therapies, including remdesivir.
FHI Clinical Scientific Advisory Experts

The FHI Clinical team of Scientific Advisory Experts serves as consultants to support our global programs and operations.

The future of clinical trials: Reimagine the way technology and data support clinical research.

Missed the webinar? Watch it now!

Successful outbreak responses depend on reliable data.

Missed the webinar? Watch it now!

Eight key lessons for COVID-19

that we've learned from previous outbreaks.

previous arrow
previous arrow
next arrow
next arrow
Slider

We manage complex clinical research in resource-limited settings

We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.

we are fhi clinical

Global Expertise

We offer a unique combination of in-country technical, regulatory and cultural knowledge and an established global presence in Africa, Asia, Europe, Latin America and North America.

Responsive Approaches

We adapt our processes and workflow as your study needs change. No matter how large or small the project, we remain agile and exact, because your research demands it.

Proven Solutions

We have research at our core. A subsidiary of FHI 360, we benefit from our parent company’s 40+ year history of clinical research and success in creating and growing CROs.

put our experience to work for you

Our mission is to address unmet research needs and achieve maximum social impact by supporting the development of life-saving vaccines and medicines.
Let us help you enter hard-to-reach markets and access the right patient populations.

Tailored Services

Tailored services to meet your needs, from protocol design and site assessments to trial planning, implementation and management.

Therapeutic Expertise

Ability to address challenges across dozens of therapeutic areas, including infectious diseases (IDs), neglected tropical diseases (NTDs), emerging and reemerging diseases, and pediatric studies.

Established Partnerships

Leverage established partnerships with leading public and private medical research organizations, pharmaceutical and biotechnology companies, academic institutions, the U.S. National Institutes of Health (NIH), the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Agency for International Development (USAID).

Monitoring COVID-19

As we monitor the rapidly changing COVID-19 situation, reliable data sources are crucial. We recommend this resource from Johns Hopkins University to better understand the pandemic’s impact.

The data sources include the World Health Organization, the U.S. Centers for Disease Control and Prevention, the European Center for Disease Prevention and Control, the National Health Commission of the People’s Republic of China, 1point3acres, Worldometers.info, BNO, state and national government health departments, local media reports, and the DXY, one of the world’s largest online communities for physicians, health care professionals, pharmacies and facilities.

News

Events

Clinical Trials of the Future

September 29, 2020
Register for this virtual plenary session at World Vaccine Congress Washington where panelists will discuss how to incorporate innovation into vaccine clinical trials, including how to apply information from the field to ongoing and future vaccine trials, use of real-world evidence for vaccine efficacy and regulatory perspectives in new development areas.

Read More »

blog